Amgen (AMGN) Non-Current Assets (2009 - 2026)

Amgen (AMGN) has reported Non-Current Assets for 18 consecutive years, with $61.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets fell 2.26% year-over-year to $61.0 billion; the TTM figure through Mar 2026 stood at $246.0 billion (down 2.8% YoY), while the FY2025 annual figure was $61.5 billion, down 2.04% from the prior year.
• Non-Current Assets came in at $61.0 billion for Q1 2026 at Amgen, down from $61.5 billion in the prior quarter.
• The five-year high for Non-Current Assets was $66.8 billion in Q4 2023, with the low at $39.6 billion in Q3 2022.
• Average Non-Current Assets over 5 years is $54.3 billion, with a median of $61.2 billion recorded in 2025.
• Across the five-year window, Non-Current Assets soared 55.64% in 2023 and decreased 6.01% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $42.9 billion in 2022, then jumped by 55.64% to $66.8 billion in 2023, then dropped by 6.01% to $62.8 billion in 2024, then slipped by 2.04% to $61.5 billion in 2025, then dropped by 0.81% to $61.0 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $61.0 billion, $61.5 billion, and $62.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.